In a filing, Perspective Therapeutics Inc revealed its affiliate Mark Austin acquired Company’s shares for reported $39500.0 on Sep 12 ’24. In the deal valued at $15.80 per share,2,500 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Hunt Jonathan Robert bought 1,800 shares, generating $17,667 in total proceeds. Upon buying the shares at $9.81, the Chief Financial Officer now owns 35,971 shares.
Before that, Woods Lori A bought 4,587 shares. Perspective Therapeutics Inc shares valued at $49,990 were divested by the Director at a price of $10.90 per share. As a result of the transaction, Woods Lori A now holds 159,985 shares, worth roughly $0.56 million.
UBS initiated its Perspective Therapeutics Inc [CATX] rating to a Buy in a research note published on October 24, 2024; the price target was $20. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in early October with a ‘”an Outperform”‘ rating. Truist began covering CATX with “Buy” recommendation on September 25, 2024. BofA Securities started covering the stock on July 25, 2024. It rated CATX as “a Buy”.
Price Performance Review of CATX
On Friday, Perspective Therapeutics Inc [AMEX:CATX] saw its stock jump 15.67% to $3.47. Over the last five days, the stock has lost -55.96%. Perspective Therapeutics Inc shares have fallen nearly -13.68% since the year began. Nevertheless, the stocks have risen 36.08% over the past one year. While a 52-week high of $19.05 was reached on 05/15/24, a 52-week low of $2.28 was recorded on 11/22/24. SMA at 50 days reached $11.52, while 200 days put it at $12.74.
Levels Of Support And Resistance For CATX Stock
The 24-hour chart illustrates a support level at 3.08, which if violated will result in even more drops to 2.69. On the upside, there is a resistance level at 3.72. A further resistance level may holdings at 3.98. The Relative Strength Index (RSI) on the 14-day chart is 14.31, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.54, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.64%. Stochastics %K at 2.76% indicates the stock is a buying.
How much short interest is there in Perspective Therapeutics Inc?
A steep rise in short interest was recorded in Perspective Therapeutics Inc stocks on 2024-10-31, dropping by -1.57 million shares to a total of 8.02 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 9.59 million shares. There was a decline of -19.54%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 09, 2024 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating .
